Sind supraventrikuläre Reentry-Tachykardien durch den kardioselektiven β-Blocker Esmolol (Brevibloc®) terminierbar?

Author： Sievers B.   Weismüller P.   Trappe H.-J.  

Publisher： Springer Publishing Company

ISSN： 0175-3851

Source： Intensivmedizin und Notfallmedizin, Vol.39, Iss.6, 2002-09, pp. : 529-536

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

β-blocker use and risk of fractures in men and women from the general population: the MONICA/KORA Augsburg cohort study

By Meisinger C.   Heier M.   Lang O.   Döring A.  

Osteoporosis International, Vol. 18, Iss. 9, 2007-09 ,pp. : 1189-1195

Springer Publishing Company

Access to resources Recommend Favorite

Tolerability of β-Blocker Initiation and Titration with Bisoprolol and Carvedilol in Congestive Heart Failure – A Randomized Comparison

By  

Cardiology, Vol. 102, Iss. 3, 2004-09 ,pp. : 160-165

Karger

Access to resources Recommend Favorite

β-Blocker Therapy in the Era of Primary Percutaneous Intervention for ST Elevation Myocardial Infarction

By  

Cardiology, Vol. 132, Iss. 2, 2015-06 ,pp. : 91-100

Karger

Access to resources Recommend Favorite

Ultraviolet light converts propranolol, a nonselective β‐blocker and potential lupus‐inducing drug, into a proinflammatory AhR ligand

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 11, 2015-11 ,pp. : 3174-3187

John Wiley & Sons Inc

Access to resources Recommend Favorite

β-Blocker Prescription and Outcomes in Hemodialysis Patients from The Japan Dialysis Outcomes and Practice Patterns Study

By  

Nephron Clin Pract, Vol. 113, Iss. 3, 2009-08 ,pp. : c132-c139

Karger

Access to resources Recommend Favorite